Hair loss drug developer Veradermics Inc. began trading Wednesday after raising $256 million in an upsized initial public offering, with Ropes & Gray LLP representing the company and Cooley LLP representing the underwriters.
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.